Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women

B•R•A•H•M•S™ sFlt-1/PlGF KRYPTOR™ Test System is available through physicians and is the first FDA-cleared biomarker test to aid in the risk assessment of progression to preeclampsia with severe features, a leading cause of maternal and fetal mortality in ... Diagnostics, Product Launch Labcorp, B•R•A•H•M•S, sFlt-1/PlGF KRYPTOR, preeclampsia

Source: HSMN NewsFeed - January 31, 2024 Category: Pharmaceuticals Source Type: news